As more genetically modified crops, insects, and fish are developed,
the scientific and policy debates on the benefits and risks of biotechnologies remain polarized.
The 2000 Cartagena Protocol on Biosafety to the Convention on Biological Diversity provides a forum to monitor developments and
address risk assessment and risk management challenges. Our latest policy brief looks at the lessons learned within the framework of the Protocol for guidance on how the international community should regulate emerging technologies, such as synthetic biology
and gene drives.
Read
the brief
